We believe that knowing research methods is not only needed to develop your own study, but serves as the basis for understanding strengths and limitations of medical information and for improving patient care. Learn how its done, learn how it works.
Projects
Recent Posts
Understanding the ACURATE neo2 TAVI Withdrawal: Key Insights
Boston Scientific has withdrawn the ACURATE neo2 TAVI series, a decision likely reflective of testing challenges rather than the valve’s quality. Prior trials revealed suboptimal performance and increased patient risks, potentially due to operator inexperience and inadequate patient selection. The learning curve for this device may have influenced outcomes, warranting improved trial designs in the future.
Misleading graph or interpretation? Easier to blame the surgeons: TAVR durability trials at TCT 2023
TAVR durability is of key importance. At TCT 2023 two new longer-term follow-up reports were published: PARTNER 3 at 5 years and Evolut Low-Risk at 4 years. A great friend … Continue reading Misleading graph or interpretation? Easier to blame the surgeons: TAVR durability trials at TCT 2023
If you think PROTECTED TAVR is a NEGATIVE trial, you should read this: Cerebral protection (Sentinel) in TAVI
Pablo Lamelas –PROTECTED TAVR study was presented in TCT 2022, bringing more discussion than ever for the use of Sentinel (cerebral embolic protection, CEP) during TAVR procedures. Many key opinion … Continue reading If you think PROTECTED TAVR is a NEGATIVE trial, you should read this: Cerebral protection (Sentinel) in TAVI
SOLACI/SIAC 2021 Guideline on the use of TAVI vs SAVR in Latin America: Presentation at ICBA Grand Rounds.
Pablo Lamelas – Last Thursday June 24th the first SOLACI/SIAC joint guideline was presented at ICBA Instituto Cardiovascular Rounds. Here we present a summary in English with outstanding faculty, an … Continue reading SOLACI/SIAC 2021 Guideline on the use of TAVI vs SAVR in Latin America: Presentation at ICBA Grand Rounds.
COLCORONA: a challenging viewpoint
by Fernando Botto, MD, MSc During 2020, most research was focused on powerful and modern anti-inflammatory drugs, unfortunately expensive and not widely available for everyone. Colchicine is a cheap and … Continue reading COLCORONA: a challenging viewpoint
CARDiOmics Club 